Kisunla
2 stories
-
healthMajor Cochrane Review Questions Effectiveness of Alzheimer's Drugs
A Cochrane review finds amyloid-targeting drugs offer little benefit, sparking debate among experts and drugmakers.
-
healthHealth Canada Approves Second Drug to Slow Alzheimer's Progression
Donanemab, approved in Canada, offers hope by slowing early Alzheimer's decline, targeting amyloid plaques.